Study population characteristics and Laboratory indexes

In total, 7562 patients infected with variant Omicron BF.7 enrolled in the study, included 55.2% female and 44.8% male. Related basic data of the patients are showed in Table 1. No prominent difference was observed in sex about the severity of the patients with the Omicron BF.7. The average age of patients infected with Omicron BF.7 was 41 years old, ranging from 0 to 99 years old, and the average age of severe patients was higher, patients with Omicron BF.7 ≥ 65 years old occupied the largest proportion. The average age of non-severe symptom and age distribution are relatively similar to this situation, and asymptomatic patients are in 45–64 years old, and patients infected with Omicron BF.7 ≥ 65 years old are fewer.

Table 1 Baseline characteristics of 7562 patients infected with COVID-19

Clinical symptoms and pre-existing diseases were missing information in 1968 patients, and fever, cough, and sore throat were similar in all patients (33.6%-42.2%) in the remaining 5594 samples. The proportion of dyspnea in patients with severe symptoms is significantly higher than other patients with mild and asymptomatic patients, but the proportion is lower in all patients. All severe patients had pre-existing diseases, the patients with hypertension accounted for the highest proportion (50%), and the proportion of pre-existing diseases in mild and asymptomatic patients was 34.42% and 23.8%, respectively.

A total of 1968 patients were missing information on vaccination. In the remaining 5594 cases, the proportion of severe patients who had not vaccinated was the highest, and the proportion of asymptomatic patients who had received booster injection was the highest, which confirmed the protective effect of the vaccine. In addition, we found that a small number of asymptomatic patients reported fever, cough, and sore throat. The characteristics of the patients with virous symptoms are shown in Table 2, and the abbreviation and full time of all laboratory indexes is exhibited in Table S1.

Table 2 All laboratory indexes of 7562 patients infected with COVID-19

Abnormal routine blood indicators

In order to explore the value and clinical feature of blood cell parameters in patients with Omicron BF.7 [27, 28]. Based on severity of clinical symptoms, the samples were divided into three groups: severe, mild and asymptomatic patients [29].

White blood cells and classification count are mainly used to understand whether the patients have been infected by the COVID-19 and subtype of COVID-19, as well as to understand the bone marrow hematopoietic situation of the subjects. The number of white blood cells in patients with severe symptoms is significantly higher than mild (P < 0.001) and asymptomatic (P = 0.61) patients (Fig. 1A). However, the number of eosinophils and basophils are significantly increased in severe patients infected with Omicron BF.7 (Fig. 1B-C). At the same time, we also observed that the lymphocyte count had no difference in every group (Fig. 1D).

Fig. 1
figure 1

Abnormal routine blood indicators. A Comparison of white blood count of patients infected with Omicron variant BF.7 with various symptoms. B Comparison of basophils count of patients infected with Omicron variant BF.7 with various symptoms. C Comparison of eosinophils count of patients infected with Omicron variant BF.7 with various symptoms. D Statistical analysis of lymphocyte count. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates asymptomatic patients

Abnormal liver function in patients infected Omicron BF.7

Since the COVID-19 outbreak, people have started to pay attention to the superimposed impact of the virus and other diseases, among them the chronic liver disease (CLD) is the most typical disease [30, 31]. Meanwhile, people have been worried that the dual impact of COVID-19 and CLD would not be harmful to COVID-19 [32, 33].

In the early days, epidemic, prevention, control and management of COVID-19 was very important. Thus, we reduced and delayed the services of other non-emergency medical conditions. However, the policy inevitably emerge affects to patients [34]. COVID-19 has had a profound influence on global public health, and with the new COVID-19 vaccines success, patients with cirrhosis should be prioritized for inoculated, while the hepatology should monitor and pay close attention to the immune response [35].

Based on the above effects of infection, we analyzed the indicators of liver in patients with virous symptoms. Our results showed that ALT, AST, AST/ALT and GGT were significantly increased in the serum of patients with severe symptoms compared with mild and asymptomatic groups (Fig. 2A and C-E). As shown in Fig. 2B, we detected the ChE level in the serum of patients, significantly lowest ChE level in patients with severe symptoms suggested that the synthesis and reserve ability of liver is decrease.

Fig. 2
figure 2

Abnormal liver function in patients infected Omicron BF.7. A IFCC method was used to detect the level of GGT, the serum level of GGT was higher in patients with severe symptoms. B The ChE level in the serum of patients significantly lower. C-E We used IFCC method to perform the level of AST/ALT, AST and ALT, the serum level of above three indicators significantly increased. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates a symptom

Abnormal kidney function in patients infected Omicron BF.7

In an analysis of more than 13,000 COVID-19 patients, COVID led to an acute kidney injury incidence of about 17%, with 5% severe enough to require dialysis, and the severity is very different [36, 37]. In the study, 32% of hospitalizations had acute kidney injury, when they left hospital, nearly half had not recover their kidney function [38,39,40].

In our study, we found CRE, BUN, and Cys-C indicators in patients with severe symptoms were significantly increased compared with mild symptoms (CRE, P = 6.7e-07; BUN, P = 1.4e-11), but there was no significant difference between asymptomatic patients and mild patients (CRE, P = 0.56; BUN, P = 0.7; Cys-C, P = 0.012) (Fig. 3A-C). Therefore, patients infected with the Omicron BF.7 need to pay attention to kidney problems in the future, especially those who had kidney disease before.

Fig. 3
figure 3

Abnormal kidney function in patients infected Omicron BF.7. A The level of CRE after patients infected with Omicron BF.7, the serum level of CRE was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. B The level of BUN after patients infected with Omicron BF.7, the serum level of BUN was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. C The level of Cys-C after patients infected with Omicron BF.7, the serum level of Cys-C was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates asymptomatic

Abnormal myocardial indexes in patients infected Omicron BF.7

The COVID-19 pandemic has resulted in more than 1 billion and 6.5 million deaths globally. In survivors, most people recovered, and some patients showed long-term symptoms, commonly referred to Post-Covid Syndromes [41, 42]. Numerous studies have shown that the risk of cardiovascular disease, including heart attack and stroke, increased significantly over a long period of time after the patients infected with Omicron BF.7, these symptoms can cause myocarditis, heart attack, cardiac arrest and sudden death and so on [43,44,45,46]. The patients could include outpatients and asymptomatic patients under the age of 50.

Then, we assessed the correlation between the progression of the patient with BF.7 and elevated myocardial indexes. Or, more generally, some biomarkers such as CK, LDHL and ɑ-HBDH were associated with symptom severity and death. Further, we detected biomarkers concentration in the serum of various groups. The analysis showed that the myocardial injury indexes CK, LDHL and ɑ-HBDH in severe patients with BF.7 were obviously increased compared with mild (CK, P = 0.0034; LDHL, P = 1.5e-06; ɑ-HBDH, P = 1.7e-06) and asymptomatic patients (CK, P = 0.43; LDHL, P = 0.06; ɑ-HBDH, P = 0.066) suffering with BF.7 (Fig. 4A-C). These results suggested that BF.7 can invade cardiovascular system and trigger lethal damage.

Fig. 4
figure 4

Abnormal myocardial indexes in patients infected Omicron BF.7. A The level of CK in patients with severe symptoms significantly higher than those who infected with mild and asymptomatic patients. B The level of LDHL after patients infected with Omicron BF.7, the serum level of LDHL was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. C The level of ɑ-HBDH after patients infected with Omicron BF.7, the serum level of ɑ-HBDH was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates asymptomatic patients

Indicators of infection in patients infected Omicron BF.7

The infection of the Omicron variant is mostly characterized by upper respiratory symptoms, but Omicron infection clinically, it is vital to be vigilant about the occurrence of severe disease, especially those high-risk groups or patients with serious potential diseases and people who are immune compromised need to pay attention to infection indicators [47, 48].

PCT is a calcitonin propetide substance, which has no hormonal activity, and calcitonin can reduce blood calcium concentration. Most of all, when the body suffered infection, PCT can trigger the synthesis of PCT in body tissues in various inflammatory substances. Some related studies have reported that PCT levels in severe patients with Omicron BF.7 are significantly higher than in mild patients, many patients with Omicron BF.7 have elevated PCT without bacterial infection. CRP is one of the acute phase reaction proteins and one of the most commonly used indicators of infection, and its level reflects the strength of the inflammatory storm in the body [49].

Our results showed that afore-mentioned two infection indicators in severe patients significantly increased. Both the mild (CRP, P = 1.7e-12; PCT, P = 0.0013) and asymptomatic groups (CRP, P = 1.2e-05; PCT, P = 7.2e-05) have more lower level compared with the severe symptoms (Fig. 5A-B). It is worth noting that CRP and PCT were significantly increased in the serum of patients with severe and mild symptoms relative to asymptomatic patients. These results suggested that significantly higher CRP and PCT levels in patients with severe symptoms is a common feature of Omicron BF.7 patients.

Fig. 5
figure 5

Indicators of infection in patients infected Omicron BF.7. A The level of CRP after patients infected with Omicron BF.7, the serum level of CRP was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. B The level of PCT after patients infected with Omicron BF.7, the serum level of PCT was higher in patients with severe symptoms than in patients with mild and asymptomatic patients. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates asymptomatic

Glucose level and electrolyte imbalance in patients infected Omicron BF.7

Clinical studies have suggested that the glucose levels are associated with the prognosis of patients with COVID-19. The authors observed that COVID-19 can transfer monocytes into their partners after infecting monocytes, the result arrest the function of T cells and lead to the death of lung epithelial cells [50,51,52]. These data explain why the adaptive immune response of diabetic patients after infection with the COVID-19 is weakened, why lung function is impaired, and clearly expose the axis of mitochondrial reactive oxygen species/HIF-1α/glycolysis, suggesting that targeting HIF-1α may be a strategy to develop new drugs for the treatment of COVID-19 [53, 54].

Moreover, we also detected the levels of Glu and ions. As shown in Fig. 6A, glucometer in patients with severe symptoms obviously higher than those with mild (P = 0.031) and asymptomatic patients (P = 4.4e-05). The phenomenon indirectly suggested that the patients with severe symptoms could have more higher proportion of diabetic patients. Otherwise, the patients with BF.7 all showed that Na+ and Cl ions concentration was decreased (Fig. 6B-C). Most remarkably, it is more pronounced in severe disease, indicating the patients with severe symptoms exist the phenomenon about electrolyte imbalance.

Fig. 6
figure 6

Glucose level and electrolyte imbalance in patients infected Omicron BF.7. A Statistical analysis of the glucose level after patients infected Omicron BF.7, hexokinase method was used to detect the level of glucose. C Statistical analysis image of the ions level after patients infected Omicron BF.7, level of ions was measured by the method of ion selective electrode. The red color indicates severe symptom, green color indicates mild symptom and blue color indicates asymptomatic

Source link